MSP, in partnership with Vitrian and Morgan Stanley Real Estate Investing, today announced the successful sale of a 352,000 square foot pharmaceutical manufacturing and distribution facility located in New Albany, Ohio.
Originally acquired in 2024, the partnership enhanced the asset’s value through the execution of a long-term, full-building lease with Hims & Hers Health, Inc. (NYSE: HIMS), a leading digital health and wellness platform.
Constructed in 2022, the Class A facility offers highly flexible industrial and manufacturing capabilities, including significant investment in state-of-the-art, FDA-regulated current good manufacturing practices (cGMP) infrastructure supporting cleanroom, laboratory, and advanced storage operations.
The property is strategically located in the rapidly expanding New Albany submarket within the Columbus region. Since 2021, the area has attracted nearly $36 billion in corporate investment across data center, semiconductor, pharmaceutical, and advanced manufacturing sectors, reinforcing its position as a premier hub for next-generation industrial growth.
This transaction underscores MSP’s continued focus on identifying and executing high-conviction life sciences investment opportunities in leading growth markets.